Mar 07, 2023 / 04:10PM GMT
Joshua Thomas Jennings - TD Cowen, Research Division - MD & Senior Research Analyst
Okay. Good morning. I'm Josh Jennings, Cowen Medical Devices team. We're moving right through the medical devices track, but we are incorporating some medical device part of a consumer hybrid into this track. And thankfully, with the executive team from Johnson & Johnson, we have Executive Vice President and Chief Financial Officer, Joe Wolk; and Vice President of Investor Relations, Jessica Moore. Joe, Jessica. Josh, we got 3 Js up here. Can't lose. Can't lose.
Thank you guys for participating in Cowen Healthcare -- TD Cowen Healthcare Conference, and great to see you in person.
Joseph J. Wolk - Johnson & Johnson - Executive VP & CFO
Same here. Thanks, Josh, for having us.
Questions and Answers:
Joshua Thomas Jennings - TD Cowen, Research Division - MD & Senior Research AnalystMaybe to start, I just wanted to talk about some of the headwinds. I know Johnson & Johnson reports first, at least in
Trustpilot
